Addressing the “Nitric Oxide Crisis” in Cardiovascular–Kidney–Metabolic Syndrome: Therapeutic Potential of the Inorganic Nitrate–Nitrite–NO Pathway
Obesity Reviews · 2026
DOI: 10.1111/obr.70021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Obesity Reviews, 2026. Verfasst von Guang-Zhi Liao und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cardiovascular Disease, Heart Failure Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Nitrates, Nitric Oxide, Nitrites. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 214 Literaturangaben. Gefördert von: Chinese Academy of Medical Science Innovation Fund for Medical Science, National High Level Hospital Clinical Research Funding, Beijing Natural Science Foundation.
Abstract (Originalsprache)
Cardiovascular–kidney–metabolic (CKM) syndrome is a complex interaction of cardiovascular diseases, chronic kidney disease (CKD), and metabolic disorders, with its global prevalence rising due to increasing obesity and metabolic risk factors. The convergence of these conditions significantly worsens patient outcomes, leading to higher morbidity and mortality rates. Key pathophysiological mechanisms underpinning CKM syndrome include insulin resistance, oxidative stress, inflammation, and vascular dysfunction, all of which are exacerbated by reduced nitric oxide (NO) bioavailability and associated signaling dysfunctions. In clinical practice, organic nitrate has been used as NO donors; however, issues such as tolerance, side effects, and endothelial damage limit their effectiveness. The inorganic nitrate–nitrite–NO pathway offers a promising alternative, as emerging evidence from animal and human studies suggests that enhancing this pathway can significantly improve the progression of metabolic disorders, cardiovascular diseases, and CKD. The potential mechanisms may lie in its ability to improve the core pathophysiological processes of CKM syndrome, including inflammation, oxidative stress, insulin resistance, and vascular dysfunction. This review synthesizes current preclinical and clinical studies, highlighting the effects of inorganic nitrate and nitrite in managing CKM syndrome and suggesting avenues for future exploration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cardiovascular Disease, Heart Failure Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing, China.
- Key Laboratory of Clinical Research for Cardiovascular Medications, National Health Committee, Beijing, China.
ORCID-Profile: Yu-Hui Zhang, Jian Zhang
Förderung
- Chinese Academy of Medical Science Innovation Fund for Medical Science
- National High Level Hospital Clinical Research Funding
- Beijing Natural Science Foundation
Zitieren
APA
Liao, G. Z., He, C. H., Zhang, Y. H., & Zhang, J. (2026). Addressing the “Nitric Oxide Crisis” in Cardiovascular–Kidney–Metabolic Syndrome: Therapeutic Potential of the Inorganic Nitrate–Nitrite–NO Pathway. Obesity Reviews. https://doi.org/10.1111/obr.70021
Vancouver
Liao GZ, He CH, Zhang YH, Zhang J. Addressing the “Nitric Oxide Crisis” in Cardiovascular–Kidney–Metabolic Syndrome: Therapeutic Potential of the Inorganic Nitrate–Nitrite–NO Pathway. Obesity Reviews. 2026. doi:10.1111/obr.70021
BibTeX
@article{Liao2026,
author = {Liao, Guang-Zhi and He, Chun-Hui and Zhang, Yu-Hui and Zhang, Jian},
title = {Addressing the “Nitric Oxide Crisis” in Cardiovascular–Kidney–Metabolic Syndrome: Therapeutic Potential of the Inorganic Nitrate–Nitrite–NO Pathway},
journal = {Obesity Reviews},
year = {2026},
doi = {10.1111/obr.70021}
}
EUVIMED